| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrivent Biopharma, Inc. (AVBP) has 9 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. AVBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 550.0K | $15.87M | - | |
| Pres | 150.0K | $4.33M | - | |
| CFO | 140.0K | $4.04M | - | |
| COO | 130.0K | $3.75M | - | |
| Other | 130.0K | $3.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Hillhouse Investment Management, Ltd. | 10% Owner | Buy | 555,555 | $18.00 | $9,999,990.00 | +14.1% | -25.7% | +31.9% | |
| Jan 30, 2024 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +17.2% | -25.7% | +31.9% | |
| Jan 30, 2024 | Gordon Carl L74 | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +17.2% | -25.7% | +31.9% | |
| Jan 30, 2024 | Healy James | Director | Buy | 444,444 | $18.00 | $7,999,992.00 | +35.5% | -25.7% | +31.9% |